Evidence map›Paper›PMID 24239028›Full record

ReviewTrends in pharmacological sciences2013

AKAP signaling complexes: pointing towards the next generation of therapeutic targets?

Jessica L Esseltine, John D Scott

Abstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Mitochondria signaling pathways in allergic asthma.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
    Review
  8. Review
  9. Article
  10. Disruptors of AKAP-Dependent Protein-Protein Interactions.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jessica L EsseltineHoward Hughes Medical Institute, Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, USA.
John D Scott

Funding

Anchored Kinase Signaling Mechanisms in Cardiac HypertrophyR01HL088366 · NHLBI · UNIVERSITY OF WASHINGTON · PI SCOTT, JOHN D · 2008 to 2012
$2.0M
Howard Hughes Medical InstituteNHLBI NIH HHS R01 HL088366
6 · The paper itself

Abstract

A-kinase anchoring proteins (AKAPs) streamline signal transduction by localizing signaling enzymes with their substrates. Great strides have been made in elucidating the role of these macromolecular signaling complexes as new binding partners and novel AKAPs are continually being uncovered. The mechanics and dynamics of these multi-enzyme assemblies suggest that AKAP complexes are viable targets for therapeutic intervention. This review will highlight recent advances in AKAP research focusing on local signaling events that are perturbed in disease.

Indexed as

A Kinase Anchor ProteinsAnimalsHumansMolecular Targeted TherapySignal TransductionSubstrate SpecificityA Kinase Anchor ProteinsAKAPCa(2+)diseaseinterfering peptideprotein kinaseprotein phosphatasesignal transduction

Identifiers

PMID24239028
PMCPMC3879114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.